Report cover image

Interbody Fusion Device Market Size, Share, and Trends Analysis, Global, 2025-2031, MedCore, Includes: ALIF Market, PLIF Market, and 4 more

Publisher iData Research, Inc.
Published Apr 17, 2025
Length 139 Pages
SKU # IDR20001699

Description

The global interbody fusion market was valued at over $3.1 billion in 2024.

It is projected to grow at a CAGR of 4.3% to surpass $4.2 billion by 2031.

The full report suite includes segmentation for:

Anterior Lumbar Interbody Fusion (ALIF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)
Cervical Interbody Fusion (CIF)
VBR/Corpectomy
Expandable Interbody Devices

Market Data Included

Unit Sales
Average Selling Prices (ASPs)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data to 2024
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Global Interbody Fusion Device Market Trends

The primary limiter in the spinal fusion market is the rise of minimally invasive surgical (MIS) interbody devices.
MIS techniques reduce tissue trauma, lower complication rates, and shorten surgery duration.
Positive clinical outcomes have fueled adoption in mature markets and are expected to similarly affect emerging markets.
Preference for MIS over open techniques continues to impact growth potential of traditional interbody devices.

Global Interbody Fusion Device Market Share Insights

1 Medtronic

Market leader in 2024, with strong dominance in North America and parts of Asia-Pacific.
Key products include:
Elevate™ expandable cage
Anatomic® PTC and Cornerstone® PSR (cervical segment)
Capstone® cage, Cornerstone L ASR®, and other bone dowels/wedges
ARTiC™ line of 3D-printed metal devices
Medtronic also leads in VBR and expandable interbody segments.

2 DePuy Synthes

Second-largest global competitor in 2024.
Offers CFRP (carbon fiber reinforced polymer) lumbar interbody cages and various bone/non-bone devices.
Strong market presence in Western Europe and Asia-Pacific contributes significantly to its share.

3 Globus Medical / NuVasive

Major competitor post-2023 merger.
Anticipated to gain market share through:
Complementary global scale
Expanded commercial reach
Extensive product portfolio in spine and orthopedics
Strong surgeon engagement and R&D investment
Combined strengths position the merged entity for continued growth across all interbody subsegments.

Market Segmentation Summary

Anterior Lumbar Interbody Fusion (ALIF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)
Cervical Interbody Fusion (CIF)
VBR/Corpectomy Devices
Expandable Interbody Devices

Research Scope Summary

Regions Covered

North America: Canada, United States
Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda

Base Year: 2024
Forecast Period: 2025–2031
Historical Data: 2021–2023

Quantitative Data

Procedure Numbers
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices

Qualitative Data

Market Growth Trends
Market Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Disease Overviews

Data Sources

Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database

Table of Contents

139 Pages
Interbody Fusion Market
7.1 Executive Summary
7.1.1 Global Interbody Fusion Market Overview
7.1.2 Competitive Analysis
7.1.3 Procedure Segmentation
7.1.4 Market Segmentation
7.1.5 Regions Included
7.2 Introduction
7.2.1 ALIF
7.2.2 PLIF
7.2.3 TLIF
7.2.4 CIF
7.2.5 VBR/Corpectomy
7.3 Procedure Numbers
7.3.1 Total Interbody Fusion Procedures
7.3.2 ALIF Procedures
7.3.3 PLIF Procedures
7.3.4 TLIF Procedures
7.3.5 CIF Procedures
7.3.6 VBR/Corpectomy Interbody Device Procedures
7.3.7 Expandable Interbody Device Procedures
7.4 Market Overview
7.4.1 By Segment
7.4.2 By Region
7.5 Market Analysis and Forecast
7.5.1 Total Interbody Fusion Market
7.5.2 ALIF Market
7.5.3 PLIF Market
7.5.4 TLIF Market
7.5.5 CIF Market
7.5.6 VBR/Corpectomy Interbody Device Market
7.5.7 Expandable Interbody Device Market
7.6 Drivers and Limiters
7.6.1 Market Drivers
7.6.2 Market Limiters
7.7 Competitive Market Share Analysis
Chart 7-1: Interbody Fusion Market, Global, 2024 & 2031
Chart 7-2: Interbody Fusion Procedures, Global, 2024
Chart 7-3: Interbody Fusion Procedures by Region, Global, 2021 – 2031
Chart 7-4: Interbody Fusion Device Market by Segment, Global, 2021 – 2031
Chart 7-5: Interbody Fusion Device Market by Region, Global, 2021 – 2031
Chart 7-6: Leading Competitors, Interbody Fusion Market, Global, 2024
Figure 7-1: Interbody Fusion Procedure Segmentation
Figure 7-2: Interbody Fusion Market Segmentation
Figure 7-3: Interbody Fusion Regions Covered, Global (1 of 2)
Figure 7-4: Interbody Fusion Regions Covered, Global (2 of 2)
Figure 7-5: Interbody Fusion Procedures by Segment, Global, 2021 – 2031
Figure 7-6: Interbody Fusion Procedures by Region, Global, 2021 – 2031
Figure 7-7: Interbody Fusion Procedures by Country, North America, 2021 – 2031
Figure 7-8: Interbody Fusion Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-9: Interbody Fusion Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-10: Interbody Fusion Procedures by Country, Western Europe, 2021 – 2031
Figure 7-11: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-12: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-13: Interbody Fusion Procedures by Country, Middle East, 2021 – 2031
Figure 7-14: Interbody Fusion Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-15: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-16: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-17: Interbody Fusion Procedures by Country, Africa, 2021 – 2031
Figure 7-18: ALIF Procedures by Region, Global, 2021 – 2031
Figure 7-19: ALIF Procedures by Country, North America, 2021 – 2031
Figure 7-20: ALIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-21: Deformity Correction Thoracolumbar Fixation Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-22: ALIF Procedures by Country, Western Europe, 2021 – 2031
Figure 7-23: ALIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-24: ALIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-25: ALIF Procedures by Country, Middle East, 2021 – 2031
Figure 7-26: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-27: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-28: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-29: ALIF Procedures by Country, Africa, 2021 – 2031
Figure 7-30: PLIF Procedures by Region, Global, 2021 – 2031
Figure 7-31: PLIF Procedures by Country, North America, 2021 – 2031
Figure 7-32: PLIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-33: PLIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-34: PLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 7-35: PLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-36: PLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-37: PLIF Procedures by Country, Middle East, 2021 – 2031
Figure 7-38: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-39: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-40: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-41: PLIF Procedures by Country, Africa, 2021 – 2031
Figure 7-42: TLIF Procedures by Region, Global, 2021 – 2031
Figure 7-43: TLIF Procedures by Country, North America, 2021 – 2031
Figure 7-44: TLIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-45: TLIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-46: TLIF Procedures by Country, Western Europe, 2021 – 2031
Figure 7-47: TLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-48: TLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-49: TLIF Procedures by Country, Middle East, 2021 – 2031
Figure 7-50: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-51: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-52: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-53: TLIF Procedures by Country, Africa, 2021 – 2031
Figure 7-54: CIF Procedures by Region, Global, 2021 – 2031
Figure 7-55: CIF Procedures by Country, North America, 2021 – 2031
Figure 7-56: CIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-57: CIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-58: CIF Procedures by Country, Western Europe, 2021 – 2031
Figure 7-59: CIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-60: CIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-61: CIF Procedures by Country, Middle East, 2021 – 2031
Figure 7-62: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-63: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-64: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-65: CIF Procedures by Country, Africa, 2021 – 2031
Figure 7-66: VBR/Corpectomy Procedures by Region, Global, 2021 – 2031
Figure 7-67: VBR/Corpectomy Procedures by Country, North America, 2021 – 2031
Figure 7-68: VBR/Corpectomy Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-69: VBR/Corpectomy Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-70: VBR/Corpectomy Procedures by Country, Western Europe, 2021 – 2031
Figure 7-71: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-72: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-73: VBR/Corpectomy Procedures by Country, Middle East, 2021 – 2031
Figure 7-74: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-75: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-76: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-77: VBR/Corpectomy Procedures by Country, Africa, 2021 – 2031
Figure 7-78: Expandable Procedures by Region, Global, 2021 – 2031
Figure 7-79: Expandable Procedures by Country, North America, 2021 – 2031
Figure 7-80: Expandable Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
Figure 7-81: Expandable Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
Figure 7-82: Expandable Procedures by Country, Western Europe, 2021 – 2031
Figure 7-83: Expandable Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
Figure 7-84: Expandable Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
Figure 7-85: Expandable Procedures by Country, Middle East, 2021 – 2031
Figure 7-86: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
Figure 7-87: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
Figure 7-88: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
Figure 7-89: Expandable Procedures by Country, Africa, 2021 – 2031
Figure 7-90: Interbody Fusion Device Market by Segment, Global, 2021 – 2031 (US$M)
Figure 7-91: Interbody Fusion Device Market by Region, Global, 2021 – 2031 (US$M)
Figure 7-92: Interbody Fusion Market, Global, 2021 – 2031
Figure 7-93: Units Sold by Region, Interbody Fusion Market, Global, 2021 – 2031
Figure 7-94: Average Selling Price by Region, Interbody Fusion Market, Global, 2021 – 2031 (US$)
Figure 7-95: Market Value by Region, Interbody Fusion Market, Global, 2021 – 2031 (US$M)
Figure 7-96: ALIF Market, Global, 2021 – 2031
Figure 7-97: Units Sold by Region, ALIF Market, Global, 2021 – 2031
Figure 7-98: Average Selling Price by Region, ALIF Market, Global, 2021 – 2031 (US$)
Figure 7-99: Market Value by Region, ALIF Market, Global, 2021 – 2031 (US$M)
Figure 7-100: PLIF Market, Global, 2021 – 2031
Figure 7-101: Units Sold by Region, PLIF Market, Global, 2021 – 2031
Figure 7-102: Average Selling Price by Region, PLIF Market, Global, 2021 – 2031 (US$)
Figure 7-103: Market Value by Region, PLIF Market, Global, 2021 – 2031 (US$M)
Figure 7-104: TLIF Market, Global, 2021 – 2031
Figure 7-105: Units Sold by Region, TLIF Market, Global, 2021 – 2031
Figure 7-106: Average Selling Price by Region, TLIF Market, Global, 2021 – 2031 (US$)
Figure 7-107: Market Value by Region, TLIF Market, Global, 2021 – 2031 (US$M)
Figure 7-108: CIF Market, Global, 2021 – 2031
Figure 7-109: Units Sold by Region, CIF Market, Global, 2021 – 2031
Figure 7-110: Average Selling Price by Region, CIF Market, Global, 2021 – 2031 (US$)
Figure 7-111: Market Value by Region, CIF Market, Global, 2021 – 2031 (US$M)
Figure 7-112: VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031
Figure 7-113: Units Sold by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031
Figure 7-114: Average Selling Price by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031 (US$)
Figure 7-115: Market Value by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031 (US$M)
Figure 7-116: Expandable Interbody Device Market, Global, 2021 – 2031
Figure 7-117: Units Sold by Region, Expandable Interbody Device Market, Global, 2021 – 2031
Figure 7-118: Average Selling Price by Region, Expandable Interbody Device Market, Global, 2021 – 2031 (US$)
Figure 7-119: Market Value by Region, Expandable Interbody Device Market, Global, 2021 – 2031 (US$M)
Figure 7-120: Leading Competitors, Interbody Fusion Market, Global, 2024

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us